-
Interim NADIM ADJUVANT Data Suggest Adjuvant Chemo-IO May Reduce Recurrence Risk in Patients Following Complete Resection
-
Final FLAURA2 OS Data Show Osimertinib Plus Chemo Offers Benefit Compared with Monotherapy
-
Potential Impact of GLP1-RAs on TKI-induced Weight Gain in Patients with NSCLC
-
No “Known” Risk Factors: The Health Consequences of Radiation Therapy
-
Discussion Covered Updates, Strategies, and Controversies in Lung Cancer Staging
-
No PFS, OS Benefit Seen in Final Results from PACIFIC-2
-
WCLC Attendees Hear Preview of Proposed Changes for the 9th Edition of the TNM Staging Classification for Thoracic Cancers
-
Treatment of Immunotherapy-Related Dermatologic Toxicities: An Interview with Dr. Mario Lacouture
-
A Holistic Approach to Patient Care
Society News
-
IASLC Lectureships Focus on Contributions of Leaders in Thoracic Oncology
Tuesday morning, nine expert clinicians and researchers in the field will give award lectures in honor of their contributions to the treatment of lung cancer.
-
Session to Report Results of IASLC’s First Diversity, Equity, and Inclusion Survey
Drs. Narjust Florez and Cecilia Pompili will co-chair the session, which will also include tips for improving inclusion in clinical trials, creating a mutually respective work environment, and more.
-
IASLC Award Recognizes Importance of Teamwork in Cancer Care
The association’s most prestigious award was presented to five multidisciplinary teams from around the world during the IASLC Award Ceremony.
-
Don’t Miss Your Last Chance to Visit the Exhibit Hall
From seeing the latest advances in thoracic oncology to connecting with colleagues in the Membership Lounge, you can do it all in the Exhibit Hall.
-
Order Your Copy of the IASLC 50th Anniversary History Book Today
Edited by lung cancer legends Drs. Fred R. Hirsch and Paul A. Bunn, the book explores the many advances in thoracic oncology treatment throughout the past five decades.
-
IASLC Journals See Continued Success Throughout Past Year
Editors-in-Chief Drs. Alex A. Adjei and Emily Stone will talk with members during a Meet-the-Editor session on Monday afternoon.
-
IASLC President-Elect Reflects on Importance of Prevention, Screening, Biomarker Testing and More
Dr. Caicun Zhou discusses his plans for WCLC 2024 as well as his goals for his time as IASLC President.
-
2024 Distinguished Service Award Recipients Honored During Opening Plenary Session
Drs. Kwun Fong, Claudia Henschke, Erik Thunnissen, and Julie Brahmer were recognized for their pioneering efforts in the field of thoracic oncology.
-
Patient Advocate Ivy B. Elkins Leaves Lasting Legacy
Ms. Elkins, co-founder of the EGFR Resisters advocacy group, will be remembered for her warm and energetic approach to furthering lung cancer research efforts.
-
Journal of Thoracic Oncology’s Impact Factor Rises Again; JTO Clinical and Research Reports Receives First Impact Factor
The IASLC’s official journal now ranks second among 100 respiratory medicine journals and 13th among 322 oncology journals.